1. Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels. (11th March 2013) Authors: Semerano, L.; Biton, J.; Delavallée, L.; Duvallet, E.; Assier, E.; Bessis, N.; Bernier, E.; Dhellin, O.; Grouard‐Vogel, G.; Boissier, M.‐C. Journal: Clinical and experimental immunology Issue: Volume 172:Number 1(2013:Apr.) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗